查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513667

週邊藥物洗脫球囊的全球市場：產業分析、規模、佔有率、成長、趨勢與預測（2024-2033）

Peripheral Drug Eluting Balloon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 273 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了一份關於全球週邊藥物洗脫球囊市場的綜合研究報告。該報告全面評估了關鍵的市場動態，包括市場驅動因素、趨勢、市場驅動因素、課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 週邊藥物洗脫球囊市場規模（2024 年）：9.486 億美元
  • 市場預測（2033 年）：19.505 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：8.3%

週邊藥物洗脫球囊市場-調查範圍

週邊藥物洗脫球囊透過將藥物直接輸送到動脈壁、抑制再狹窄和改善血流，在周邊動脈疾病 (PAD) 的治療中發揮重要作用。這些球囊用於各種醫療保健環境，包括醫院、診所和門診中心，我們提供各種藥物配方和球囊尺寸，以滿足不同患者的需求。 PAD 盛行率的增加、球囊技術的進步以及對微創治療的日益偏好正在推動市場成長。

市場驅動因素：

全球週邊藥物洗脫球囊市場受到幾個關鍵因素的推動，其中包括影響全球數百萬人的 PAD 盛行率上升。對提供持續藥物輸送和降低再狹窄率的有效治療方案的需求正在推動藥物洗脫球囊的採用。技術進步，例如開發具有改進的藥物塗層和輸送機制的下一代球囊，正在改善治療效果和患者結果。此外，擴大採用微創手術和優惠的報銷政策進一步促進了市場的成長。

市場限制因素：

儘管外圍藥物洗脫球囊市場有望實現成長，但仍面臨新興市場監管合規性、成本高和認知度低等課題。關於藥物洗脫球囊的批准和使用的嚴格規定給製造商帶來了巨大的合規負擔。藥物洗脫球囊和相關程序的高成本也對廣泛使用構成了障礙，特別是在醫療保健預算有限的地區。此外，新興國家對 PAD 和可用治療方案的認識不足，阻礙了市場滲透。

市場機會

技術創新、人口趨勢和醫療保健基礎設施的擴張正在為週邊藥物洗脫球囊市場提供重大成長機會。將先進的藥物配方和新的藥物傳輸技術融入球囊裝置中有望改善治療效果並擴大應用範圍。醫療保健基礎設施投資不斷增加，尤其是在新興國家，預計將創造新的市場機會。策略聯盟、研發投資以及實施具有成本效益的解決方案對於利用這些機會並保持市場領先地位至關重要。

本報告涵蓋的主要問題

  • 推動週邊藥物洗脫球囊市場成長的關鍵因素是什麼？
  • 哪些藥物配方和應用正在推動外周藥物洗脫球囊在各種醫療保健環境中的採用？
  • 技術進步如何改變週邊藥物洗脫球囊市場的競爭格局？
  • 誰是外圍藥物洗脫球囊市場的主要參與者？
  • 全球週邊藥物洗脫球囊市場的新趨勢和未來前景如何？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第三章主要市場趨勢

  • 影響市場的主要趨勢
  • 藥物包衣創新/發展趨勢

第 4 章增值見解

  • 依地區劃分的產品採用/使用分析
  • 監管場景
  • 技術評估
  • 價值鏈分析
  • 最近的產品批准和發佈
  • 波特的分析
  • 產品 USP 分析

第五章市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第 6 章 COVID-19 危機分析

  • 新冠肺炎 (COVID-19) 與影響分析
    • 透過藥物包衣
    • 依症狀
    • 依動脈型
    • 依最終用戶
    • 依地區
  • 2024 年市場情景

第七章全球市場需求量分析

  • 過去的市場量分析（2019-2023 年）
  • 目前與未來的市場量預測（2024-2033 年）
    • 年成長趨勢分析

第 8 章世界市場 - 價格分析

  • 以藥物包衣進行區域價格分析
  • 價格明細
    • 製造商等級定價
    • 經銷商級定價
  • 世界平均價格分析基準
  • 定價假設

第九章全球市場需求（金額）分析

  • 過往市值分析（2019-2023 年）
  • 當前與未來市場價值的預測（2024-2033 年）
    • 年成長趨勢分析
    • 絕對利潤機會分析
  • 獲利機會場景

第 10 章全球市場分析：依藥物塗層分類

  • 簡介/主要發現
  • 過去的市場規模與數量分析：依藥物包衣分類（2019-2023）
  • 目前與未來的市場規模/數量分析/預測：依藥物包衣劃分（2024-2033 年）
    • 紫杉醇藥物包衣
    • 西羅莫司藥物包衣
    • 其他
  • 藥物包衣的市場吸引力分析

第 11 章全球市場分析：依症狀

  • 簡介/主要發現
  • 過去的市場規模/數量分析：依症狀分類（2019-2023 年）
  • 目前/未來的市場規模/數量分析/預測：依症狀分類（2024-2033 年）
    • 週邊動脈疾病
    • 週邊動脈瘤
    • 支架內再狹窄
    • 其他
  • 症狀市場吸引力分析

第 12 章全球市場分析：依動脈類型

  • 簡介/主要發現
  • 過去的市場規模和交易量分析：依動脈類型劃分（2019-2023 年）
  • 目前/未來市場規模/數量分析/預測：依動脈類型劃分（2024-2033 年）
    • 頸動脈
    • 女性動脈
    • 髂動脈
    • 下動脈
  • 依動脈型進行市場吸引力分析

第 13 章全球市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 過去的市場規模/數量分析：依最終用戶劃分（2019-2023 年）
  • 目前/未來的市場規模/數量分析/預測：依最終用戶劃分（2024-2033 年）
    • 醫院
    • 日間手術中心/門診
    • 心導管室
  • 最終用戶的市場吸引力分析

第 14 章世界市場分析：依地區

  • 簡介
  • 過去的市場規模/銷售分析：依地區劃分（2019-2023 年）
  • 當前與未來的市場價值/數量分析/預測：依地區劃分（2024-2033 年）
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東/非洲
  • 區域市場吸引力分析

第15章北美市場分析

第 16 章拉丁美洲市場分析

第 17 章歐洲市場分析

第18章東亞市場分析

第十九章南亞市場分析

第20章大洋洲市場

第21章中東/非洲市場分析

第22章市場結構分析

  • 依公司層級進行市場分析
  • 主要公司市佔率分析
  • 市場現況分析

第23章競爭分析

  • 競爭對手儀表板
  • 製造商的品牌和促銷策略
  • 主要發展分析
  • 衝突詳情
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • MicroPort Scientific Corporation（Endovastec（TM））
    • Medtronic Plc.
    • Cardinal Health, Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE &Co. KG
    • Becton, Dickinson and Company
    • WL Gore &Associates Inc.
    • Getinge AB
    • Terumo Corp
    • Kyoto Medical Planning Co Ltd
    • iVascular SLU
    • AMG International GmbH
    • ENDOCOR GmbH
    • Meril Life Sciences Pvt. Ltd.
    • Nano Therapeutics Pvt Ltd
    • Koninklijke Philips NV
    • REVA Medical

第 24 章先決條件與使用的縮寫

第25章研究方法

簡介目錄
Product Code: PMRREP27211

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Drug Eluting Balloons Market Size (2024E): USD 948.6Million
  • Projected Market Value (2033F): USD 1950.5 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.3%

Peripheral Drug Eluting Balloons Market - Report Scope:

Peripheral drug eluting balloons play a crucial role in the treatment of peripheral artery disease (PAD) by delivering medication directly to the arterial walls to inhibit restenosis and improve blood flow. These balloons are used in various healthcare settings, including hospitals, clinics, and outpatient centers, offering a range of drug formulations and balloon sizes to cater to different patient needs. Market growth is driven by the increasing prevalence of PAD, advancements in balloon technology, and a growing preference for minimally invasive procedures.

Market Growth Drivers:

The global peripheral drug eluting balloons market is propelled by several key factors, including the rising incidence of PAD, which affects millions of people worldwide. The demand for effective treatment options that offer sustained drug delivery and reduced restenosis rates is driving the adoption of drug eluting balloons. Technological advancements, such as the development of next-generation balloons with improved drug coatings and delivery mechanisms, enhance treatment efficacy and patient outcomes. Additionally, the increasing adoption of minimally invasive procedures and favorable reimbursement policies are further contributing to market growth.

Market Restraints:

Despite promising growth prospects, the peripheral drug eluting balloons market faces challenges related to regulatory compliance, high costs, and limited awareness in emerging markets. Stringent regulations governing the approval and use of drug eluting balloons impose significant compliance burdens on manufacturers. The high cost of these devices and associated procedures can also be a barrier to widespread adoption, particularly in regions with limited healthcare budgets. Furthermore, the lack of awareness about PAD and available treatment options in developing countries hinders market penetration.

Market Opportunities:

The peripheral drug eluting balloons market presents significant growth opportunities driven by technological innovations, demographic trends, and expanding healthcare infrastructure. The integration of advanced drug formulations and novel delivery technologies into balloon devices is expected to enhance therapeutic outcomes and broaden the application scope. Increasing investments in healthcare infrastructure, particularly in emerging economies, are anticipated to create new market opportunities. Strategic collaborations, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
  • Which drug formulations and applications are driving the adoption of peripheral drug eluting balloons across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the peripheral drug eluting balloons market?
  • Who are the key players contributing to the peripheral drug eluting balloons market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global peripheral drug eluting balloons market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral drug eluting balloons market, including Medtronic, B. Braun Melsungen AG, and Boston Scientific Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced drug eluting balloon solutions, including devices with enhanced drug coatings and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving peripheral drug eluting balloons landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec(TM))
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

  • Paclitaxel Drug Coating
  • Sirolimus drug Coating

Indication:

  • Peripheral Arterial Disease
  • Peripheral Aneurysms
  • In-Stent Restenosis

Artery Type:

  • Carotid Arteries
  • Fem-Pop Arteries
  • Iliac Arteries
  • Infrapop Arteries

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Drug Coating Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption/ Usage Analysis, by region
  • 4.2. Regulatory Scenario
  • 4.3. Technology Assessment
  • 4.4. Value Chain Analysis
  • 4.5. Recent Product Approvals and Launches
  • 4.6. Porter's Analysis
  • 4.7. Product USP Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Peripheral Vascular Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growth in Healthcare Spending
    • 5.2.2. Growth in Geriatric Population
    • 5.2.3. Rising Number of Peripheral Surgeries
    • 5.2.4. Technological Advancements
    • 5.2.5. Regulatory Landscape
    • 5.2.6. Cost of Procedures
    • 5.2.7. Product Adoption Rate and Demand
    • 5.2.8. Increase in Research and Development
    • 5.2.9. Pharmaceutical Industry Consolidation Activities
    • 5.2.10. Top Companies' Historical Growth
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Drug Coating
    • 6.1.2. By Indication
    • 6.1.3. By Artery Type
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand in Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Drug Coating
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis
  • 9.3. Revenue Opportunity Scenario

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Coating

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Drug Coating, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Drug Coating, 2024-2033
    • 10.3.1. Paclitaxel Drug Coating
    • 10.3.2. Sirolimus drug Coating
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Drug Coating

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2024-2033
    • 11.3.1. Peripheral Arterial Disease
    • 11.3.2. Peripheral Aneurysms
    • 11.3.3. In-Stent Restenosis
    • 11.3.4. Others
  • 11.4. Market Attractiveness Analysis, by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery Type

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Artery Type, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Artery Type, 2024-2033
    • 12.3.1. Carotid Artery
    • 12.3.2. Fem-Pop Artery
    • 12.3.3. Iliac Artery
    • 12.3.4. Infrapop Artery
  • 12.4. Market Attractiveness Analysis, by Artery Type

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2024-2033
    • 13.3.1. Hospitals
    • 13.3.2. Ambulatory Surgical Centers/Outpatients
    • 13.3.3. Cardiac Catheterization Labs
  • 13.4. Market Attractiveness Analysis, by End User

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. South Asia
    • 14.3.5. East Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis, by Region

15. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Drug Coating
    • 15.3.3. By Indication
    • 15.3.4. By Artery Type
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug Coating
    • 15.4.3. By Indication
    • 15.4.4. By Artery Type
    • 15.4.5. By End User
  • 15.5. PESTLE Analysis
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast
    • 15.9.1. U.S. Market Analysis
      • 15.9.1.1. Introduction
      • 15.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.9.1.2.1. By Drug Coating
        • 15.9.1.2.2. By Indication
        • 15.9.1.2.3. By Artery Type
        • 15.9.1.2.4. By End User
    • 15.9.2. Canada Market Analysis
      • 15.9.2.1. Introduction
      • 15.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.9.2.2.1. By Drug Coating
        • 15.9.2.2.2. By Indication
        • 15.9.2.2.3. By Artery Type
        • 15.9.2.2.4. By End User

16. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Mexico
      • 16.3.1.2. Brazil
      • 16.3.1.3. Argentina
      • 16.3.1.4. Rest of Latin America
    • 16.3.2. By Drug Coating
    • 16.3.3. By Indication
    • 16.3.4. By Artery Type
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug Coating
    • 16.4.3. By Indication
    • 16.4.4. By Artery Type
    • 16.4.5. By End User
  • 16.5. PESTLE Analysis
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast
    • 16.9.1. Mexico Market Analysis
      • 16.9.1.1. Introduction
      • 16.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.1.2.1. By Drug Coating
        • 16.9.1.2.2. By Indication
        • 16.9.1.2.3. By Artery Type
        • 16.9.1.2.4. By End User
    • 16.9.2. Brazil Market Analysis
      • 16.9.2.1. Introduction
      • 16.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.2.2.1. By Drug Coating
        • 16.9.2.2.2. By Indication
        • 16.9.2.2.3. By Artery Type
        • 16.9.2.2.4. By End User
    • 16.9.3. Argentina Market Analysis
      • 16.9.3.1. Introduction
      • 16.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.3.2.1. By Drug Coating
        • 16.9.3.2.2. By Indication
        • 16.9.3.2.3. By Artery Type
        • 16.9.3.2.4. By End User

17. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Nordic Countries
      • 17.3.1.9. Rest of Europe
    • 17.3.2. By Drug Coating
    • 17.3.3. By Indication
    • 17.3.4. By Artery Type
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug Coating
    • 17.4.3. By Indication
    • 17.4.4. By Artery Type
    • 17.4.5. By End User
  • 17.5. PESTLE Analysis
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast
    • 17.9.1. Germany Market Analysis
      • 17.9.1.1. Introduction
      • 17.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.1.2.1. By Drug Coating
        • 17.9.1.2.2. By Indication
        • 17.9.1.2.3. By Artery Type
        • 17.9.1.2.4. By End User
    • 17.9.2. Italy Market Analysis
      • 17.9.2.1. Introduction
      • 17.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.2.2.1. By Drug Coating
        • 17.9.2.2.2. By Indication
        • 17.9.2.2.3. By Artery Type
        • 17.9.2.2.4. By End User
    • 17.9.3. France Market Analysis
      • 17.9.3.1. Introduction
      • 17.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.3.2.1. By Drug Coating
        • 17.9.3.2.2. By Indication
        • 17.9.3.2.3. By Artery Type
        • 17.9.3.2.4. By End User
    • 17.9.4. U.K. Market Analysis
      • 17.9.4.1. Introduction
      • 17.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.4.2.1. By Drug Coating
        • 17.9.4.2.2. By Indication
        • 17.9.4.2.3. By Artery Type
        • 17.9.4.2.4. By End User
    • 17.9.5. Spain Market Analysis
      • 17.9.5.1. Introduction
      • 17.9.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.5.2.1. By Drug Coating
        • 17.9.5.2.2. By Indication
        • 17.9.5.2.3. By Artery Type
        • 17.9.5.2.4. By End User
    • 17.9.6. BENELUX Market Analysis
      • 17.9.6.1. Introduction
      • 17.9.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.6.2.1. By Drug Coating
        • 17.9.6.2.2. By Indication
        • 17.9.6.2.3. By Artery Type
        • 17.9.6.2.4. By End User
    • 17.9.7. Russia Market Analysis
      • 17.9.7.1. Introduction
      • 17.9.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.7.2.1. By Drug Coating
        • 17.9.7.2.2. By Indication
        • 17.9.7.2.3. By Artery Type
        • 17.9.7.2.4. By End User
    • 17.9.8. Nordic Countries Market Analysis
      • 17.9.8.1. Introduction
      • 17.9.8.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.8.2.1. By Drug Coating
        • 17.9.8.2.2. By Indication
        • 17.9.8.2.3. By Artery Type
        • 17.9.8.2.4. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Drug Coating
    • 18.3.3. By Indication
    • 18.3.4. By Artery Type
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug Coating
    • 18.4.3. By Indication
    • 18.4.4. By Artery Type
    • 18.4.5. By End User
  • 18.5. PESTLE Analysis
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis
  • 18.9. Country Level Analysis & Forecast
    • 18.9.1. China Market Analysis
      • 18.9.1.1. Introduction
      • 18.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.1.2.1. By Drug Coating
        • 18.9.1.2.2. By Indication
        • 18.9.1.2.3. By Artery Type
        • 18.9.1.2.4. By End User
    • 18.9.2. Japan Market Analysis
      • 18.9.2.1. Introduction
      • 18.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.2.2.1. By Drug Coating
        • 18.9.2.2.2. By Indication
        • 18.9.2.2.3. By Artery Type
        • 18.9.2.2.4. By End User
    • 18.9.3. South Korea Market Analysis
      • 18.9.3.1. Introduction
      • 18.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.3.2.1. By Drug Coating
        • 18.9.3.2.2. By Indication
        • 18.9.3.2.3. By Artery Type
        • 18.9.3.2.4. By End User

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. India
      • 19.3.1.2. Indonesia
      • 19.3.1.3. Malaysia
      • 19.3.1.4. Thailand
      • 19.3.1.5. Rest of South Asia
    • 19.3.2. By Drug Coating
    • 19.3.3. By Indication
    • 19.3.4. By Artery Type
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Drug Coating
    • 19.4.3. By Indication
    • 19.4.4. By Artery Type
    • 19.4.5. By End User
  • 19.5. PESTLE Analysis
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis
  • 19.9. Country Level Analysis & Forecast
    • 19.9.1. India Market Analysis
      • 19.9.1.1. Introduction
      • 19.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.1.2.1. By Drug Coating
        • 19.9.1.2.2. By Indication
        • 19.9.1.2.3. By Artery Type
        • 19.9.1.2.4. By End User
    • 19.9.2. Indonesia Market Analysis
      • 19.9.2.1. Introduction
      • 19.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.2.2.1. By Drug Coating
        • 19.9.2.2.2. By Indication
        • 19.9.2.2.3. By Artery Type
        • 19.9.2.2.4. By End User
    • 19.9.3. Malaysia Market Analysis
      • 19.9.3.1. Introduction
      • 19.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.3.2.1. By Drug Coating
        • 19.9.3.2.2. By Indication
        • 19.9.3.2.3. By Artery Type
        • 19.9.3.2.4. By End User
    • 19.9.4. Thailand Market Analysis
      • 19.9.4.1. Introduction
      • 19.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.4.2.1. By Drug Coating
        • 19.9.4.2.2. By Indication
        • 19.9.4.2.3. By Artery Type
        • 19.9.4.2.4. By End User

20. Oceania Market 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Drug Coating
    • 20.3.3. By Indication
    • 20.3.4. By Artery Type
    • 20.3.5. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Drug Coating
    • 20.4.3. By Indication
    • 20.4.4. By Artery Type
    • 20.4.5. By End User
  • 20.5. PESTLE Analysis
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis
  • 20.9. Country Level Analysis & Forecast
    • 20.9.1. Australia Market Analysis
      • 20.9.1.1. Introduction
      • 20.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.9.1.2.1. By Drug Coating
        • 20.9.1.2.2. By Indication
        • 20.9.1.2.3. By Artery Type
        • 20.9.1.2.4. By End User
    • 20.9.2. New Zealand Market Analysis
      • 20.9.2.1. Introduction
      • 20.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.9.2.2.1. By Drug Coating
        • 20.9.2.2.2. By Indication
        • 20.9.2.2.3. By Artery Type
        • 20.9.2.2.4. By End User

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. Israel
      • 21.3.1.4. South Africa
      • 21.3.1.5. North Africa
      • 21.3.1.6. Rest of Middle East and Africa
    • 21.3.2. By Drug Coating
    • 21.3.3. By Indication
    • 21.3.4. By Artery Type
    • 21.3.5. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Drug Coating
    • 21.4.3. By Indication
    • 21.4.4. By Artery Type
    • 21.4.5. By End User
  • 21.5. PESTLE Analysis
  • 21.6. Market Trends
  • 21.7. Key Market Participants - Intensity Mapping
  • 21.8. Drivers and Restraints - Impact Analysis
  • 21.9. Country Level Analysis & Forecast
    • 21.9.1. GCC Countries Market Analysis
      • 21.9.1.1. Introduction
      • 21.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.1.2.1. By Drug Coating
        • 21.9.1.2.2. By Indication
        • 21.9.1.2.3. By Artery Type
        • 21.9.1.2.4. By End User
    • 21.9.2. Turkey Market Analysis
      • 21.9.2.1. Introduction
      • 21.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.2.2.1. By Drug Coating
        • 21.9.2.2.2. By Indication
        • 21.9.2.2.3. By Artery Type
        • 21.9.2.2.4. By End User
    • 21.9.3. Israel Africa Market Analysis
      • 21.9.3.1. Introduction
      • 21.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.3.2.1. By Drug Coating
        • 21.9.3.2.2. By Indication
        • 21.9.3.2.3. By Artery Type
        • 21.9.3.2.4. By End User
    • 21.9.4. South Africa Market Analysis
      • 21.9.4.1. Introduction
      • 21.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.4.2.1. By Drug Coating
        • 21.9.4.2.2. By Indication
        • 21.9.4.2.3. By Artery Type
        • 21.9.4.2.4. By End User
    • 21.9.5. North Africa Market Analysis
      • 21.9.5.1. Introduction
      • 21.9.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.5.2.1. By Drug Coating
        • 21.9.5.2.2. By Indication
        • 21.9.5.2.3. By Artery Type
        • 21.9.5.2.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis, by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Branding and Promotional Strategies, By Manufacturers
  • 23.3. Key Development Analysis
  • 23.4. Competition Deep Dive
    • 23.4.1. Abbott Laboratories
      • 23.4.1.1. Overview
      • 23.4.1.2. Product Portfolio
      • 23.4.1.3. Sales Footprint
      • 23.4.1.4. Key Financials
      • 23.4.1.5. SWOT Analysis
      • 23.4.1.6. Key Developments
      • 23.4.1.7. Strategy Overview
        • 23.4.1.7.1. Marketing Strategy
        • 23.4.1.7.2. Product Strategy
        • 23.4.1.7.3. Channel Strategy
    • 23.4.2. Boston Scientific Corporation
      • 23.4.2.1. Overview
      • 23.4.2.2. Product Portfolio
      • 23.4.2.3. Sales Footprint
      • 23.4.2.4. Key Financials
      • 23.4.2.5. SWOT Analysis
      • 23.4.2.6. Key Developments
      • 23.4.2.7. Strategy Overview
        • 23.4.2.7.1. Marketing Strategy
        • 23.4.2.7.2. Product Strategy
        • 23.4.2.7.3. Channel Strategy
    • 23.4.3. Cook Medical Inc.
      • 23.4.3.1. Overview
      • 23.4.3.2. Product Portfolio
      • 23.4.3.3. Sales Footprint
      • 23.4.3.4. Key Financials
      • 23.4.3.5. SWOT Analysis
      • 23.4.3.6. Key Developments
      • 23.4.3.7. Strategy Overview
        • 23.4.3.7.1. Marketing Strategy
        • 23.4.3.7.2. Product Strategy
        • 23.4.3.7.3. Channel Strategy
    • 23.4.4. MicroPort Scientific Corporation (Endovastec(TM))
      • 23.4.4.1. Overview
      • 23.4.4.2. Product Portfolio
      • 23.4.4.3. Sales Footprint
      • 23.4.4.4. Key Financials
      • 23.4.4.5. SWOT Analysis
      • 23.4.4.6. Key Developments
      • 23.4.4.7. Strategy Overview
        • 23.4.4.7.1. Marketing Strategy
        • 23.4.4.7.2. Product Strategy
        • 23.4.4.7.3. Channel Strategy
    • 23.4.5. Medtronic Plc.
      • 23.4.5.1. Overview
      • 23.4.5.2. Product Portfolio
      • 23.4.5.3. Sales Footprint
      • 23.4.5.4. Key Financials
      • 23.4.5.5. SWOT Analysis
      • 23.4.5.6. Key Developments
      • 23.4.5.7. Strategy Overview
        • 23.4.5.7.1. Marketing Strategy
        • 23.4.5.7.2. Product Strategy
        • 23.4.5.7.3. Channel Strategy
    • 23.4.6. Cardinal Health, Inc.
      • 23.4.6.1. Overview
      • 23.4.6.2. Product Portfolio
      • 23.4.6.3. Sales Footprint
      • 23.4.6.4. Key Financials
      • 23.4.6.5. SWOT Analysis
      • 23.4.6.6. Key Developments
      • 23.4.6.7. Strategy Overview
        • 23.4.6.7.1. Marketing Strategy
        • 23.4.6.7.2. Product Strategy
        • 23.4.6.7.3. Channel Strategy
    • 23.4.7. B. Braun Melsungen AG
      • 23.4.7.1. Overview
      • 23.4.7.2. Product Portfolio
      • 23.4.7.3. Sales Footprint
      • 23.4.7.4. Key Financials
      • 23.4.7.5. SWOT Analysis
      • 23.4.7.6. Key Developments
      • 23.4.7.7. Strategy Overview
        • 23.4.7.7.1. Marketing Strategy
        • 23.4.7.7.2. Product Strategy
        • 23.4.7.7.3. Channel Strategy
    • 23.4.8. BIOTRONIK SE & Co. KG
      • 23.4.8.1. Overview
      • 23.4.8.2. Product Portfolio
      • 23.4.8.3. Sales Footprint
      • 23.4.8.4. Key Financials
      • 23.4.8.5. SWOT Analysis
      • 23.4.8.6. Key Developments
      • 23.4.8.7. Strategy Overview
        • 23.4.8.7.1. Marketing Strategy
        • 23.4.8.7.2. Product Strategy
        • 23.4.8.7.3. Channel Strategy
    • 23.4.9. Becton, Dickinson and Company
      • 23.4.9.1. Overview
      • 23.4.9.2. Product Portfolio
      • 23.4.9.3. Sales Footprint
      • 23.4.9.4. Key Financials
      • 23.4.9.5. SWOT Analysis
      • 23.4.9.6. Key Developments
      • 23.4.9.7. Strategy Overview
        • 23.4.9.7.1. Marketing Strategy
        • 23.4.9.7.2. Product Strategy
        • 23.4.9.7.3. Channel Strategy
    • 23.4.10. W. L. Gore & Associates Inc.
      • 23.4.10.1. Overview
      • 23.4.10.2. Product Portfolio
      • 23.4.10.3. Sales Footprint
      • 23.4.10.4. Key Financials
      • 23.4.10.5. SWOT Analysis
      • 23.4.10.6. Key Developments
      • 23.4.10.7. Strategy Overview
        • 23.4.10.7.1. Marketing Strategy
        • 23.4.10.7.2. Product Strategy
        • 23.4.10.7.3. Channel Strategy
    • 23.4.11. Getinge AB
      • 23.4.11.1. Overview
      • 23.4.11.2. Product Portfolio
      • 23.4.11.3. Sales Footprint
      • 23.4.11.4. Key Financials
      • 23.4.11.5. SWOT Analysis
      • 23.4.11.6. Key Developments
      • 23.4.11.7. Strategy Overview
        • 23.4.11.7.1. Marketing Strategy
        • 23.4.11.7.2. Product Strategy
        • 23.4.11.7.3. Channel Strategy
    • 23.4.12. Terumo Corp
      • 23.4.12.1. Overview
      • 23.4.12.2. Product Portfolio
      • 23.4.12.3. Sales Footprint
      • 23.4.12.4. Key Financials
      • 23.4.12.5. SWOT Analysis
      • 23.4.12.6. Key Developments
      • 23.4.12.7. Strategy Overview
        • 23.4.12.7.1. Marketing Strategy
        • 23.4.12.7.2. Product Strategy
        • 23.4.12.7.3. Channel Strategy
    • 23.4.13. Kyoto Medical Planning Co Ltd
      • 23.4.13.1. Overview
      • 23.4.13.2. Product Portfolio
      • 23.4.13.3. Sales Footprint
      • 23.4.13.4. Key Financials
      • 23.4.13.5. SWOT Analysis
      • 23.4.13.6. Key Developments
      • 23.4.13.7. Strategy Overview
        • 23.4.13.7.1. Marketing Strategy
        • 23.4.13.7.2. Product Strategy
        • 23.4.13.7.3. Channel Strategy
    • 23.4.14. iVascular S.L.U
      • 23.4.14.1. Overview
      • 23.4.14.2. Product Portfolio
      • 23.4.14.3. Sales Footprint
      • 23.4.14.4. Key Financials
      • 23.4.14.5. SWOT Analysis
      • 23.4.14.6. Key Developments
      • 23.4.14.7. Strategy Overview
        • 23.4.14.7.1. Marketing Strategy
        • 23.4.14.7.2. Product Strategy
        • 23.4.14.7.3. Channel Strategy
    • 23.4.15. AMG International GmbH
      • 23.4.15.1. Overview
      • 23.4.15.2. Product Portfolio
      • 23.4.15.3. Sales Footprint
      • 23.4.15.4. Key Financials
      • 23.4.15.5. SWOT Analysis
      • 23.4.15.6. Key Developments
      • 23.4.15.7. Strategy Overview
        • 23.4.15.7.1. Marketing Strategy
        • 23.4.15.7.2. Product Strategy
        • 23.4.15.7.3. Channel Strategy
    • 23.4.16. ENDOCOR GmbH
      • 23.4.16.1. Overview
      • 23.4.16.2. Product Portfolio
      • 23.4.16.3. Sales Footprint
      • 23.4.16.4. Key Financials
      • 23.4.16.5. SWOT Analysis
      • 23.4.16.6. Key Developments
      • 23.4.16.7. Strategy Overview
        • 23.4.16.7.1. Marketing Strategy
        • 23.4.16.7.2. Product Strategy
        • 23.4.16.7.3. Channel Strategy
    • 23.4.17. Meril Life Sciences Pvt. Ltd.
      • 23.4.17.1. Overview
      • 23.4.17.2. Product Portfolio
      • 23.4.17.3. Sales Footprint
      • 23.4.17.4. Key Financials
      • 23.4.17.5. SWOT Analysis
      • 23.4.17.6. Key Developments
      • 23.4.17.7. Strategy Overview
        • 23.4.17.7.1. Marketing Strategy
        • 23.4.17.7.2. Product Strategy
        • 23.4.17.7.3. Channel Strategy
    • 23.4.18. Nano Therapeutics Pvt Ltd
      • 23.4.18.1. Overview
      • 23.4.18.2. Product Portfolio
      • 23.4.18.3. Sales Footprint
      • 23.4.18.4. Key Financials
      • 23.4.18.5. SWOT Analysis
      • 23.4.18.6. Key Developments
      • 23.4.18.7. Strategy Overview
        • 23.4.18.7.1. Marketing Strategy
        • 23.4.18.7.2. Product Strategy
        • 23.4.18.7.3. Channel Strategy
    • 23.4.19. Koninklijke Philips N.V.
      • 23.4.19.1. Overview
      • 23.4.19.2. Product Portfolio
      • 23.4.19.3. Sales Footprint
      • 23.4.19.4. Key Financials
      • 23.4.19.5. SWOT Analysis
      • 23.4.19.6. Key Developments
      • 23.4.19.7. Strategy Overview
        • 23.4.19.7.1. Marketing Strategy
        • 23.4.19.7.2. Product Strategy
        • 23.4.19.7.3. Channel Strategy
    • 23.4.20. REVA Medical
      • 23.4.20.1. Overview
      • 23.4.20.2. Product Portfolio
      • 23.4.20.3. Sales Footprint
      • 23.4.20.4. Key Financials
      • 23.4.20.5. SWOT Analysis
      • 23.4.20.6. Key Developments
      • 23.4.20.7. Strategy Overview
        • 23.4.20.7.1. Marketing Strategy
        • 23.4.20.7.2. Product Strategy
        • 23.4.20.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology